Kiniksa Pharmaceuticals International, plc Quarterly Operating Margin in % from Q4 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Kiniksa Pharmaceuticals International, plc quarterly/annual Operating Margin history and growth rate from Q4 2022 to Q3 2024.
  • Kiniksa Pharmaceuticals International, plc Operating Margin for the quarter ending September 30, 2024 was -6.83 %, a 11.6% increase year-over-year.
  • Kiniksa Pharmaceuticals International, plc annual Operating Margin for 2023 was -9.32 %, a 310% decline from 2022.
  • Kiniksa Pharmaceuticals International, plc annual Operating Margin for 2022 was 4.44 %.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -6.83 +0.9 +11.6% Jul 1, 2024 Sep 30, 2024
Q2 2024 -8.12 -21.7 -160% Apr 1, 2024 Jun 30, 2024
Q1 2024 -10.1 -19.4 -209% Jan 1, 2024 Mar 31, 2024
Q4 2023 -9.32 -13.8 -310% Oct 1, 2023 Dec 31, 2023
Q3 2023 -7.73 Jul 1, 2023 Sep 30, 2023
Q2 2023 13.6 Apr 1, 2023 Jun 30, 2023
Q1 2023 9.26 Jan 1, 2023 Mar 31, 2023
Q4 2022 4.44 Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.